Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117789 | SCV000152050 | benign | not specified | 2015-11-06 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000117789 | SCV000203106 | benign | not specified | 2014-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085286 | SCV000636705 | benign | Nance-Horan syndrome | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312190 | SCV000846985 | benign | Inborn genetic diseases | 2015-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000826994 | SCV000968601 | benign | not provided | 2018-05-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Breakthrough Genomics, |
RCV000826994 | SCV005274348 | benign | not provided | criteria provided, single submitter | not provided |